
|Articles|October 1, 2003
Hydrophilic IOL yields low incidence of Nd:YAG capsulotomy
Author(s)Lynda Charters
New York-The 1-year follow-up of the Hydroview IOL (Bausch & Lomb) indicates that the lens is safe and provides excellent postoperative visual outcomes, a low incidence of Nd:YAG capsulotomy, and no cases of decentration, according to Douglas Grayson, MD, FACS.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
8 things to know about aflibercept 8 mg for retinal vascular disease
2
How AI is reshaping ophthalmology in 2025 and beyond
3
From bench to bedside: Evolving realities of gene therapy for inherited retinal diseases
4
Reimagining dry eye care: Focus on sustained tear production
5







































